NCT05673083Active, not recruiting
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Source: ClinicalTrials.gov · Last updated 4 Sept 2025
Brief summary (registry, in English)
The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with multiple myeloma. The main question it aims to answer are: • Does All4Cure effect patient activation as assessed by the PAM-13 survey? Participants will be asked to: * fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation. * fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website. * fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 22 Dec 2022
- Start date
- 1 Mar 2023
- Primary completion date
- Mar 2026
- Lead sponsor
- All4Cure
- Diseases
- Multiple myeloma
- NCT number
- NCT05673083
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Mar 2023 to the primary completion date, Mar 2026
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Patients will be excluded who are unable to engage with All4Cure or are already participants in All4Cure.
Who the study is looking for
- have a diagnosis of multiple myeloma.
- are aged 18 years and older.
- can read and e-consent to participate in the study.
- can speak English.
- can complete surveys at pre-specified intervals.
- have access to a device that would allow for the completion of surveys (including at home, at work, at the oncologist's office or elsewhere).
- are cared for by a physician who is enrolled in All4Cure.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Misson Cancer + Blood Coordinator of this site? Confirm its status | Des Moines | United States | Unknown status |
| Hematology Oncology Associates of Central New York Coordinator of this site? Confirm its status | East Syracuse | United States | Unknown status |
| Highlands Oncology Group Coordinator of this site? Confirm its status | Fayetteville | United States | Unknown status |
| Oncology Consultants Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Cancer Specialists of North Florida Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
| Northwest Medical Specialties PLLC Coordinator of this site? Confirm its status | Tacoma | United States | Unknown status |
| Oklahoma Cancer Specialists and Research Institute Coordinator of this site? Confirm its status | Tulsa | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.